The Crick Institute plans to leverage Broken String’s DNA break-mapping platform to develop novel applications for ALS ...

We catch up with Mammoth Biosciences CSO Lucas Harrington after his ASGCT presentation. Harrington lays out his company's big plans in developing a range of therapeutic options using miniature Cas ...

Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate ...

Solvias says its new center complements its biologics and CGT sites in Europe and expands its testing capabilities in the ...

In one of the opening workshops at ASGCT 2024, topics around delivery methods for gene therapies and approaches to expand the gene editing toolbox dominated the discussion. The quality of the ...

Discoveries about PARP1 biology generate questions that could aid in development of new PARP1-targeting strategies.

Scientists say findings have important implications for public health, genetic counseling of carriers, and future research directions.

Prologue Medicines' platform combines computation and high-throughput biology to decode millennia of viral evolution.

Metagenomic study uncovers previously uncharacterized Cas9 nucleases, including CoCas9, which is compact, but still active ...

A U.S. District Court judge has granted Vizgen’s motion to expand its antitrust case against rival 10x Genomics and Harvard University, citing new evidence that has surfaced during the case’s ...

Access to accurate and actionable information in real-time is critical for reputation management and strategic planning. In this GEN webinar, Storyful CEO Maria Pacheco will showcase several real-time ...

Nanoparticle that penetrates the blood-brain barrier can shrink breast and brain tumors in laboratory studies.